Trial Profile
Evaluate of Tolterodine for lower urinary tract syndrome after prostate Brachytherapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 19 May 2016 New trial record